• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 10/20/2020
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: other relevant device(s) are: product id: 3389, serial/lot #: unknown.Age: this value is the average age of the patients reported in the article as specific patients could not be identified.Gender: this value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Event date: please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Chen w, yu x, wang n, jing j, ma x, li r.The therapeutic effect of deep brain stimulation at medial globus pallidus and subthalamic nucleus on treating parkinson disease.Acta medica mediterranea.2021;37(5):2293-2300.10.19193/0393-6384_2021_5_356.The objective was to explore the improvements and therapeutic effects of deep brain stimulation on the symptoms and living quality of patients with parkinson disease.A total of 82 patients with parkinson disease who underwent deep brain stimulation in the neurosurgery department at the first affiliated hospital of xi¿an jiaotong university from may 2016 to january 2019 were enrolled.The clinical symptoms, disease severity, disability, and quality of life of enrolled patients were evaluated at 1 week before the surgery and 6 months after the surgery.Reported events: 3 cases of device stimulated skin infections occurred.4 cases of post-operative intracranial infection occurred.It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.See attached literature article.
 
Manufacturer Narrative
Concomitant medical products: other relevant device(s) are: product id: 3389, serial/lot #: unknown.Age: this value is the average age of the patients reported in the article as specific patients could not be identified.Gender: this value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Event date: please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Chen w, yu x, wang n, jing j, ma x, li r.The therapeutic effect of deep brain stimulation at medial globus pallidus and subthalamic nucleus on treating parkinson disease.Acta medica mediterranea.2021;37(5):2293-2300.10.19193/0393-6384_2021_5_356.The objective was to explore the improvements and therapeutic effects of deep brain stimulation on the symptoms and living quality of patients with parkinson disease.A total of 82 patients with parkinson disease who underwent deep brain stimulation in the neurosurgery department at the first affiliated hospital of xi¿an jiaotong university from may 2016 to january 2019 were enrolled.The clinical symptoms, disease severity, disability, and quality of life of enrolled patients were evaluated at 1 week before the surgery and 6 months after the surgery.Reported events: 3 cases of device stimulated skin infections occurred.4 cases of post-operative intracranial infection occurred.It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.See attached literature article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE NEUROSTIMULATOR
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key13059633
MDR Text Key285536319
Report Number2182207-2021-02218
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
-
-